Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global PSA Test Market by Type (CLIA, ELISA, Others, ), By Application (Screening, Post-treatment Monitoring, Others, ) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global PSA Test Market by Type (CLIA, ELISA, Others, ), By Application (Screening, Post-treatment Monitoring, Others, ) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 170328 3300 Pharma & Healthcare 377 233 Pages 4.9 (32)
                                          

Market Overview:


The global PSA test market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of prostate cancer, technological advancements in PSA testing, and rising demand for early diagnosis and treatment of prostate cancer. However, the high cost of PSA tests is expected to restrain the growth of this market during the forecast period. The global PSA test market is segmented on the basis of type, application, and region. On the basis of application, it is classified into screening applications; post-treatment monitoring applications; other diagnostic applications (prostate-specific antigen density [PSAD] measurement); and research applications. By region, it is analyzed across North America (U.S., Canada), Latin America (Mexico), Europe (Germany France Italy Spain U.K.), Asia Pacific (China Japan India South Korea Australia New Zealand), and Middle East & Africa (Saudi Arabia UAE Qatar South Africa).


Global PSA Test Industry Outlook


Product Definition:


The prostate-specific antigen (PSA) test is a blood test used to screen for prostate cancer in men. PSA is a protein produced by the prostate gland. The level of PSA in the blood increases as the size of the prostate gland increases. A high level of PSA may be a sign of prostate cancer.


CLIA:


The U.S. FDA has approved the use of CEA test for prostate cancer screening, however; it is not mandatory as of now. However, many healthcare organizations are supporting its implementation and usage in PSA tests to increase their market penetration by promoting awareness about early diagnosis and treatment options available for this disease.


ELISA:


ELISA (Enzyme-Linked Immunosorbent Assay) is a test used for detecting the level of prostate-specific antigen in the blood. It also helps to identify men who may be at risk of developing PCa, or any other disease for that matter. ELISA is considered as one of the most important tests used in PSA testing market along with prostate MRI and Digital Rectal Exam (DRE).


Application Insights:


The screening application segment dominated the global PSA test market in 2017. This can be attributed to factors such as high usage rates for prostate cancer screening programs and rising awareness about early detection of the disease. For instance, according to a study published by NCBI in 2018, it was found that around 54% of men aged between 55 and 74 years had a PSA level tested during their lifetime.


In addition, key players are launching new products specifically designed for screening purposes which is further driving growth. For instance, in January 2019 Roche launched CxPlate Prostate Cancer Test with improved performance features such as faster results (20 minutes) compared to other liquid biopsies currently available in the market (2 hours).


Regional Analysis:


North America dominated the global PSA test market in 2017. The rising prevalence of prostate cancer and the presence of established healthcare facilities are some factors contributing to its growth. In addition, increasing government funding for research and development activities is also expected to drive this regional market over the forecast period.


Asia Pacific is anticipated to witness a lucrative CAGR during the forecast period owing to an increase in disposable income, growing awareness about early diagnosis, high unmet medical needs of patients & availability & adoption of innovative technologies such as point-of-care testing platforms by manufacturers coupled with an increase in investment by governments for R&D purposes are some factors driving this regional market growth. Moreover, economic development has led to improvement in living standards which has resulted into increased consumer spending on health care services thereby fueling industry expansion over the projected time frame  (2018 - 2030).


Growth Factors:


  • Increasing incidence of prostate cancer: The incidence of prostate cancer is increasing globally. This will drive the demand for PSA tests as a means to detect the disease at an early stage.
  • Growing awareness about PSA tests: There is growing awareness among men about the benefits of PSA testing in detecting prostate cancer at an early stage. This will help to boost demand for PSA tests in the coming years.
  • Advances in diagnostic technology: Technological advances are helping to make PSA testing more accurate and efficient, thus driving its adoption among men who wish to screen for prostate cancer risk factors.

Scope Of The Report

Report Attributes

Report Details

Report Title

PSA Test Market Research Report

By Type

CLIA, ELISA, Others,

By Application

Screening, Post-treatment Monitoring, Others,

By Companies

Abbott, Siemens Healthcare, DiaSorin, Roche, Beckman Coulter, PerkinElmer, Tosoh, Ortho Clinical, Fujirebio, Mediwatch, BodiTech

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

233

Number of Tables & Figures

164

Customization Available

Yes, the report can be customized as per your need.


Global PSA Test Market Report Segments:

The global PSA Test market is segmented on the basis of:

Types

CLIA, ELISA, Others,

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Screening, Post-treatment Monitoring, Others,

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Abbott
  2. Siemens Healthcare
  3. DiaSorin
  4. Roche
  5. Beckman Coulter
  6. PerkinElmer
  7. Tosoh
  8. Ortho Clinical
  9. Fujirebio
  10. Mediwatch
  11. BodiTech

Global PSA Test Market Overview


Highlights of The PSA Test Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. CLIA
    2. ELISA
    3. Others
  1. By Application:

    1. Screening
    2. Post-treatment Monitoring
    3. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the PSA Test Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global PSA Test Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


PSA Test is a blood test that measures the level of prostate-specific antigen (PSA). PSA levels may be elevated in men with prostate cancer.

Some of the major companies in the psa test market are Abbott, Siemens Healthcare, DiaSorin, Roche, Beckman Coulter, PerkinElmer, Tosoh, Ortho Clinical, Fujirebio, Mediwatch, BodiTech.

The psa test market is expected to register a CAGR of 6.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. PSA Test Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. PSA Test Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. PSA Test Market - Supply Chain
   4.5. Global PSA Test Market Forecast
      4.5.1. PSA Test Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. PSA Test Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. PSA Test Market Absolute $ Opportunity

5. Global PSA Test Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. PSA Test Market Size and Volume Forecast by Type
      5.3.1. CLIA
      5.3.2. ELISA
      5.3.3. Others
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global PSA Test Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. PSA Test Market Size and Volume Forecast by Application
      6.3.1. Screening
      6.3.2. Post-treatment Monitoring
      6.3.3. Others
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global PSA Test Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. PSA Test Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global PSA Test Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. PSA Test Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global PSA Test Demand Share Forecast, 2019-2026

9. North America PSA Test Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America PSA Test Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America PSA Test Market Size and Volume Forecast by Application
      9.4.1. Screening
      9.4.2. Post-treatment Monitoring
      9.4.3. Others
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America PSA Test Market Size and Volume Forecast by Type
      9.7.1. CLIA
      9.7.2. ELISA
      9.7.3. Others
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America PSA Test Demand Share Forecast, 2019-2026

10. Latin America PSA Test Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America PSA Test Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America PSA Test Market Size and Volume Forecast by Application
      10.4.1. Screening
      10.4.2. Post-treatment Monitoring
      10.4.3. Others
    10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America PSA Test Market Size and Volume Forecast by Type
      10.7.1. CLIA
      10.7.2. ELISA
      10.7.3. Others
    10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America PSA Test Demand Share Forecast, 2019-2026

11. Europe PSA Test Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe PSA Test Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe PSA Test Market Size and Volume Forecast by Application
      11.4.1. Screening
      11.4.2. Post-treatment Monitoring
      11.4.3. Others
    11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe PSA Test Market Size and Volume Forecast by Type
      11.7.1. CLIA
      11.7.2. ELISA
      11.7.3. Others
    11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe PSA Test Demand Share, 2019-2026

12. Asia Pacific PSA Test Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific PSA Test Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific PSA Test Market Size and Volume Forecast by Application
      12.4.1. Screening
      12.4.2. Post-treatment Monitoring
      12.4.3. Others
    12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific PSA Test Market Size and Volume Forecast by Type
      12.7.1. CLIA
      12.7.2. ELISA
      12.7.3. Others
    12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific PSA Test Demand Share, 2019-2026

13. Middle East & Africa PSA Test Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa PSA Test Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa PSA Test Market Size and Volume Forecast by Application
      13.4.1. Screening
      13.4.2. Post-treatment Monitoring
      13.4.3. Others
    13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa PSA Test Market Size and Volume Forecast by Type
      13.7.1. CLIA
      13.7.2. ELISA
      13.7.3. Others
    13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa PSA Test Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global PSA Test Market: Market Share Analysis
   14.2. PSA Test Distributors and Customers
   14.3. PSA Test Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Abbott
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Siemens Healthcare
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. DiaSorin
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Roche
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Beckman Coulter
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. PerkinElmer
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Tosoh
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Ortho Clinical
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Fujirebio
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Mediwatch
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. BodiTech
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us